Selective targeting of the repressive transcription factors YY1 and cMyc to disrupt quiescent human immunodeficiency viruses

AIDS Research and Human Retroviruses

Volumn 29, Issue 2, 2013, Pages 289-298

  Barton, Kirston ^a   Margolis, David ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE H3; MESSENGER RNA; MYC PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR YY1; VORINOSTAT;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE DISRUPTION; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROVIRUS; T LYMPHOCYTE;

CD4-POSITIVE T-LYMPHOCYTES; GENE KNOCKDOWN TECHNIQUES; GENE TARGETING; HIV LONG TERMINAL REPEAT; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION; VIRUS LATENCY; YY1 TRANSCRIPTION FACTOR;

EID: 84872975113     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0227     Document Type: Article

References (26)

1. Hanley TM and Viglianti GA: Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms. J Virol 2011;85(20):10834-10850.
2. Cismasiu VB, Paskaleva E, Suman Daya S, Canki M, Duus K, and Avram D: BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. Virology 2008; 380(2):173-181.
3. He G and Margolis DM: Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol 2002;22(9):2965-2973. (Pubitemid 34437455)
4. Archin NM, Keedy KS, Espeseth A, Dang H, Hazuda DJ, and Margolis DM: Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS 2009;23(14):1799-1806.
5. Archin NM, Espeseth A, Parker D, Cheema M, Hazuda D, and Margolis DM: Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses 2009;25(2):207-212.
6. Archin N, Liberty A, Kashuba A, et al.: Administration of vorinostat disrupts HIV-1 latency in patients on ART. Paper presented at the 18th Annual Conference on Retroviruses and Opportunistic Infections, March 2012, Seattle, W.A.
7. Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, and Greene WC: NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 2006;25(1):139-149. (Pubitemid 43077303)
8. Jiang G, Espeseth A, Hazuda DJ, and Margolis DM: c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 2007;81(20):10914-10923. (Pubitemid 47536066)
9. Tyagi M and Karn J: CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J 2007;26(24):4985-4995. (Pubitemid 350261291)
10. Castellano G, Torrisi E, Ligresti G, et al.: The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 2009;8(9):1367-1372.
11. Coull JJ, Romerio F, Sun JM, et al.: The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 2000;74(15):6790-6799. (Pubitemid 30470662)
12. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, and Li F: The c-Myc target gene network. Sem Cancer Biol 2006;16(4):253-264. (Pubitemid 44311039)
13. Kurland JF and Tansey WP: Myc-mediated transcriptional repression by recruitment of histone deacetylase. Cancer Res 2008;68(10):3624-3629.
14. Bres V, Yoshida T, Pickle L, and Jones KA: SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Mol Cell 2009;36(1):75-87.
15. Lucey BP, Nelson-Rees WA, and Hutchins GM: Henrietta Lacks, HeLa cells, and cell culture contamination. Arch Pathol Lab Med 2009;133(9):1463-1467.
16. Kutsch O, Benveniste EN, Shaw GM, and Levy DN: Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol 2002;76(17):8776-8786. (Pubitemid 34864073)
17. Kim YK, Bourgeois CF, Pearson R, et al.: Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J 2006;25(15):3596-3604. (Pubitemid 44264870)
18. Poleshko A, Palagin I, Zhang R, et al.: Identification of cellular proteins that maintain retroviral epigenetic silencing: Evidence for an antiviral response. J Virol 2008;82(5):2313-2323. (Pubitemid 351293531)
19. Verhoeven D, Sankaran S, Silvey M, and Dandekar S: Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4 + T cells in gut mucosa but enhances their rapid restoration through central memory T cells. J Virol 2008;82(8):4016-4027. (Pubitemid 351521237)
20. Keedy KS, Archin NM, Gates AT, Espeseth A, Hazuda DJ, and Margolis DM: A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J Virol 2009;83(10):4749-4756.
21. Bhandari DR, Seo KW, Jung JW, Kim HS, Yang SR, and Kang KS: The regulatory role of c-MYC on HDAC2 and PcG expression in human multipotent stem cells. J Cell Mol Med 2011;15(7):1603-1614.
22. Stojanova A, Caro C, Jarjour RJ, Oster SK, Penn LZ, and Germinario RJ: Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein. J Cell Biochem 2004;92(2):400-413.
23. Contreras X, Schweneker M, Chen CS, et al.: Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem 2009;284(11):6782-6789.
24. MacDonald VE and Howe LJ: Histone acetylation: Where to go and how to get there. Epigenetics 2009;4(3):139-143.
25. Govind CK, Qiu H, Ginsburg DS, et al.: Phosphorylated Pol II CTD recruits multiple HDACs, including Rpd3C(S), for methylation-dependent deacetylation of ORF nucleosomes. Mol Cell 2010;39(2):234-246.
26. Baritaki S, Huerta-Yepez S, Sakai T, Spandidos DA, and Bonavida B: Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: Up-regulation of DR5 and inhibition of Yin Yang 1. Mol Cancer Ther 2007;6(4):1387-1399. (Pubitemid 46712002)